 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 GLOBE NEWSWIRE -- Akero Therapeutics, Inc. Nasdaq: AKRO, a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 10:30 a.m. P.T. in San Francisco, CA. 